CD107a (LAMP-1) Antibody, anti-human, REAfinity™
Synonyms: LAMP-1, LAMPA, LGP120, LAMP1
RECOMBINANT EXTENDED VALIDATION
Bioz Star99/100 Bioz rating
56 Citations13 Images
Clone:
REA792 | H4A3
Type of antibody:
Primary antibodies, Recombinant antibodies
Isotype:
recombinant human IgG1
Applications:
ICFC, MICS, IF, IHC, MC Glossary
External link icon
Quality Assurance Certified ProductSatisfaction
guaranteed
more »
Select a conjugate:
Select a size:
Other sizes

Related products for CD107a (LAMP-1) Antibody, anti-human, REAfinity™

Intracellular flow cytometry applications
APC
APC-Vio 770
Biotin
FITC
PE
PE-Vio 615
PE-Vio 770
PerCP-Vio 700
Vio Bright B515
Vio Bright V646
Vio R667
Vio R720
VioBlue
VioGreen
Recommended dilution:
1:50
Remark:
The antibody is suited for staining of formaldehyde-fixed cells.
Data source:
Miltenyi Biotec
Conjugate:
APC
Used products:
130-111-847, 130-112-000
Description:
Jurkat cells were fixed, permeabilized, and stained with CD107a (LAMP-1) antibodies or with the corresponding REA Control (I) antibodies (left peak). Control antibodies are unstained in case of VioGreen™ and VioBright 515 fluorochromes. Flow cytometry was performed using the MACSQuant® Analyzer. The Tandem Signal Enhancer has been used to increase binding specificity of tandem-dye–conjugated antibodies. Cell debris were excluded from the analysis based on scatter signals.

Application image
MICS (MACSima Imaging Cyclic Staining) applications
APC
FITC
PE
Fixation:
frozen – PFA
Species tested:
human
Recommended dilution:
1:50
Data source:
Miltenyi Biotec
Compatible applications:
IF, IHC
Conjugate:
APC
Used products:
130-111-847, 130-112-000
Testing grade:
Fixation:
frozen – Acetone
Species tested:
human
Recommended dilution:
1:50
Data source:
Miltenyi Biotec
Compatible applications:
IF, IHC
Conjugate:
APC
Used products:
130-111-847, 130-112-000
Testing grade:
Mass cytometry applications
pure
Conjugate:
pure
Used products:
130-124-536
Extended validation for CD107a (LAMP-1) Antibody, anti-human, REAfinity™
Specificity
Epitope competition assay

In order to compare the epitope specificity of an antibody, the clone being used is compared with other known clones recognizing the same antigen in a competition assay.

Other clones
Overlap in epitope recognition with REA792
H4A3
high
508921
partial

Cells were incubated with an excess of purified unconjugated CD107a (LAMP-1) (REA792) antibody followed by staining with fluorochrome-conjugated antibodies from other known clones targeting the same antigen. Fluorescence intensity was then used to assess epitope overlap: a minimal or absent signal indicated high epitope overlap, an intermediate signal suggested partial overlap, and a strong signal reflected low overlap.

Sensitivity
Performance comparison

Selected fluorochrome conjugated antibodies from Miltenyi Biotec were compared to commercially available hybridoma clones in flow cytometry analysis.

Extended-Validation detailed information image
Extended-Validation detailed information image
Extended-Validation detailed information image
Extended-Validation detailed information image

Flow cytometric comparison of different clones for CD107a (LAMP-1). Splenocytes from Jurkat cell line were stained with CD107a (LAMP-1) antibodies and with a suitable counterstaining. As a control, CD107a (LAMP-1) antibody staining was omitted and cells were measured in the same channels. Flow cytometry was performed with the MACSQuant Analyzer. Cell debris, dead cells, and cell doublets were excluded from the analysis based on scatter signals and 4',6-diamidino-2-phenylindole (DAPI) fluorescence. No FcR Blocking Reagent was used. The recommended titers of respective antibodies from different suppliers were used.

Specifications for CD107a (LAMP-1) Antibody, anti-human, REAfinity™
Overview

Clone REA792 recognizes the CD107a antigen, also known as lysosome-associated membrane protein 1 (LAMP-1), a 110–140 kDa type I membrane glycoprotein. It is a widely expressed intracellular protein, located in the lysosomal/endosomal membrane. CD107a transiently located on the plasma membrane can be used as a marker for CD8+ T cell degranulation following stimulation. It is also expressed to a lower extent on activated NK cells.

Additional information: Clone REA792 displays negligible binding to Fc receptors.

Alternative names

LAMP-1, LAMPA, LGP120, LAMP1

Detailed product information

Technical specifications

Clone
REA792
Clonality
monoclonal
Isotype
recombinant human IgG1
Isotype control
REA Control Antibody (I), human IgG1
Host
human cell line
Type of antibody
Primary antibodies, Recombinant antibodies
Species reactivity
human
Cross-reactivity
rhesus monkey (Macaca mulatta), pigtail monkey (Macaca nemestrina), african green monkey (Chlorocebus aethiops), baboon, chimpanzee (Pan troglodytes)
Antigen
CD107a (LAMP-1)
Molecular mass of antigen [kDa]
42
Distribution of antigen
dendritic cells, epithelial cells, granulocytes, macrophages, T cells, neutrophils
Entrez Gene ID
RRID
AB_2654490, AB_2904672, AB_2819666, AB_2654476, AB_2654480, AB_2654471, AB_2654481, AB_2654488, AB_2654492, AB_2654472, AB_2654477, AB_2654485, AB_2654473, AB_2654474, AB_2654486, AB_2654482, AB_2904671, AB_2654478, AB_2654483, AB_2654493, AB_2654491, AB_2654489, AB_2654487, AB_2654484, AB_2654494, AB_2654479, AB_2654475

Recombinant antibodies at Miltenyi Biotec

As an innovation-powered company with a commitment to quality and excellence, Miltenyi Biotec applies cutting-edge methods to discover and develop newer and better antibodies to satisfy both market demand and regulatory requirements.

The Miltenyi way of generating best-in-class antibodies and antibody conjugates

At Miltenyi Biotec, we opt for recombinant antibodies, which enable sequence verification and optimization for lot-to-lot consistency, making them superior to hybridoma-based antibodies.

Infusing our unique expertise

Recombinants are the result of combining genetic material from different immunized animals, and using display technologies to screen in-house antibody libraries for the best antibodies. Additional analyses on existing hybridoma-based antibodies can also give rise to sequences contributing to novel recombinants.

Maximizing value for your research

By further re-engineering these antibody sequences, we can precisely control their properties to achieve the following benefits:

reduce undesirable binding to Fc gamma receptors,

  • eliminate destabilizing amino acid motifs,
  • increase specific bonding affinity for stronger, more accurate targeting, and
  • optimize fluorochrome conjugation for brighter and clearer signals.

In a final step, by synthesizing and cloning the resulting gene sequence, we achieve an expression vector that develops a cell line, which in turn produces a special recombinant antibody.

Better science with quality antibodies

Already in 2015, 100 of the world’s leading scientists collectively called for better standards and reproducibility in antibody production, proposing recombinant antibodies to circumvent variability (Baker, M. Reproducibility crisis: Blame it on the antibodies. Nature 521, 274–276 (2015). https://doi.org/10.1038/521274a). Moreover, by applying reverse engineering, which is encouraged by the EU Directive 2016/943 r, Miltenyi Biotec acts “[i]n the interest of innovation and fostering competition…” (§16).

Resources for CD107a (LAMP-1) Antibody, anti-human, REAfinity™
Documents and Protocols
Certificates

To access a Certificate of Analysis (CoA) follow the link below and enter the specific lot of your product.

Get certificate

Should you wish to request additional documentation, such as a Safety Data Sheet (SDS) in other languages than English or Swedish, an SDS-replacement document, or a Certificate of Origin (CoO), please direct your inquiry to your local technical support team.

Contact technical support

You have previously chosen International as your location.
What do you want to do?